The aim of the present study was to assess the frequency of stromal myofibroblasts appearance, and to further clarify whether myofibroblasts influence tumor suppression or progression. Surgical resection specimens from 152 patients with cT1-T3N0 oral squamous cell carcinoma (OSCC) were analysed. Frequency of myofibroblasts within tumoral stroma was assessed immunohistochemically and compared with other clinically and histopathological factors. Immunohistochemical reaction for alpha-smooth muscle actin showed positive cells in stroma of 84.2% (n=128) of OSCC. Increased presence of myofibroblasts in the tumor stroma was significantly correlated with T stage (P = 0.019), presence of occult neck metastases (P < 0.001), regional recurrence (P = 0.037), and distant metastases (P = 0.008). There was also association between presence of myofibroblasts and patient's survival (P = 0.009). Presence of myofibroblasts was not associated with local recurrence, tumor cellular differentation, mode of invasion, and bone invasion. Results of this study suggest that myofibroblast proliferation facilitates tumour invasion, occurrence of occult neck disease and distant metastases. Survival rate was poorer in patients with abundant myofibroblasts. Further investigations on tumor-associated stroma at invasive front are needed in order to provide new diagnostic markers and therapeutic strategies.
INTRODUCTION
Oral cancer is common worldwide, particularly in developing countries, where it constitutes up to 25% of all malignancies 1 . Squamous cell carcinoma is the most common histological type of oral cancer. It is associated with great morbidity and mortality rates that have not improved in decades despite early detection and therapeutic advances 2 . Extensive research in the field of tumorigenesis has shown that tumor progression depends on its genetic characteristics and on interactions with its environment 3 . The tumor microenvironment comprise cancer cells, stromal cells and extracellular matrix (ECM) 4 . One of the major components of tumor-associated stroma are fibroblasts and myofibroblasts. Due to their ability to produce collagen and ECM proteins, it has been suggested that these cells represent an important factor in the development of the desmoplastic reaction that facilitates invasion both in vitro and in vivo [5] [6] [7] . Most of the biological markers of metastases are derived from cancer cells rather than the stroma. However, assessment of the tumor-host borderline provides a correlation with prognosis and understanding the mode of tumour cell invasion which enables prediction of the treatment outcome [8] [9] [10] . The aim of the present study is to assess the abundance of stromal myofibroblasts (SMF), and to correlate it with cancer recurrence and patient's survival. In addition, we investigated the relationship between myofibroblast appearance and the incidence of occult neck disease in order to clarify the indications for elective lymphadenectomy and the outcome of treatment. Follow-up protocol consisted of history and physical examination every 3, 6, 9 and 12 months, in the first, second, third, and fourth year of follow-up, respectively. Post-treatment CT scans (oral cavity and neck) were performed within 1 and 5 years after surgical treatment.
 

MATERIALS AND METHODS
Informed
Other repeated imaging was done only in patients with signs/symptoms, not routinely in asymptomatic patients.
Statistical Analysis
Numerical data were presented with mean and standard deviation and categorical with absolute and relative frequencies. Follow-up intervals were calculated in months from the date of first treatment to the date of last follow-up or death. Association between presence of myofibroblasts and clinicopathological parameters was performed by Chi-square test or
Fisher's exact test when appropriate. Multivariate analysis of variables related to regional metastases was done using logistic regression. The Kaplan-Meier method was applied for survival analysis, and the statistical significance was evaluated using log-rank test. Regression data were presented with regression coefficients and odds ratio with 95% confidence intervals   (95% CIs). All statistics was done using MedCalc statistical software (MedCalc Statistical Software ver. 13.0.2, MedCalc Software bvba, Ostend, Belgium). P values of < 0.05 were considered statistically significant.
 
RESULTS
Over the 5-year period, 183 patients were primarily surgically treated. After eliminating patients who did not meet inclusion criteria, 152 patients were egliable for study. The study group included 124 men (81.6%) and 28 (18.4%) women with a median age of 59 (range 34-85 years). Clinicopathological characteristics of the study group are summarized in Table 1 Table 2 . Abundant presence of myofibroblasts in the tumor stroma significantly correlated with T stage, presence of occult neck metastases, regional recurrence, and distant metastases. There was also an association between the presence of myofibroblasts and patient's survival. Patients whose specimens demonstrated abundant myofibroblasts had a disease specific survival rate of 67.2% at 5-years compared with 91.9% for patients with scanty myofibroblasts which is statistically significant ( Figure   4 ). Presence of myofibroblasts was not associated with age, gender, local recurrence, tumor cell differentation, mode of invasion, bone invasion, and margin status. We also carried out a multivariate analysis, which identified high myofibroblast scores and poorly differantiated tumors as unfavorable prognostic factors with respect to occult neck metastases ( Table 3 ).
The odds of occult neck disease for patients with high myofibroblast scores and poorly differentiated tumors were 8.68 and 2.31 higher compared to patients with low myofibroblasts scores and moderate/well differantiated tumors, respectively (P < 0.001, 95% CI: 2.87-26.29; P = 0.044, 95% CI: 1.02-5.25). Postoperative radiotherapy was administered to 69 of 152 (45.4%) patients. At the end of the study, thirty-four of the patients had died (22.4%) of  
DISCUSSION
The most significant prognostic factor of survival for patients with OSCC is the status of regional lymph nodes. The presence of regional metastases reduces survival of these patients up to 50% and indicates the higher risk for regional recurrence and distant metastasis 13, 14 .
However opposite to what has been reported in other types of human carcinoma in which myofibroblasts were found prior to the invasive process [21] [22] [23] . The findings in our study, which showed a statistically significant association between the frequency of myofibroblast appearance and poorer survival rates, are in accordance with prior reports 20, [24] [25] [26] . On the other hand, some authors did not find a significant association between myofibroblasts and patients survival 17 . SMF scores were statistically insignificant with respect to local recurrence (P = 0.064). On the contrary, Vered et al 24 observed that abundance of SMF had an independent adverse effect on local control. In our study, lymph node metastases and regional recurrence occurred more frequently in the abundant myofibroblast group, which was also demonstrated by the findings of other authors 17, 26 . However, this is the first study addressing its proliferation regarding occurrence of occult neck disease. Furthermore, to our knowledge, this is the first evidence showing a significantly increased occurrence of distant metastases in patients with abundant myofibroblast appearance. Myofibroblast appearance increased with increasing tumor invasiveness, although no statistically significant correlation was found (P = 0.089). In a series of 84 biopsy materials from patients with OSCC, Kawashiri et al 26 observed similar results, suggesting that the frequency of these cells increased gradually with mode of invasion. In addition, de-Assis et al 27 found that the presence of SMF was higher in tumors with a more diffuse histological pattern of invasion.
 
Recent evidence suggests that myofibroblasts represent the main effector of tumor-associated stroma, which facilitate the invasion process and inhibit the host immune response. Also there is increasing evidence that some of SMF actually represent epithelial malignant cells that have undergone epithelial-mesenhymal transition (EMT), the process by which tumour cells lose E-cadherin-dependent intercellular adhesion and enhance motility, thus becoming able to penetrate into surrounding tissues 28 . This hypothesis was further supported by the triple immunostaining procedure, which showed that loss of E-cadherin among carcinoma cells being in direct contact with adjacent SMF 24 . Furthermore, carcinoma cells can induce a reversal of these changes, termed mesenchymal-to-epithelial transitions (METs), by which carcinoma-derived stromal cells adopt epithelial characteristics establishing new tumour foci, which could be a reasonable explanation for the high disease reccurence and poorer survival rates obtained when an abundance of myofibroblasts was found 29 .
In addition, some authors demonstrated that interaction of SMF with OSCC cells leads to an activation of the EGFR signalling system in tumor with critical role not only in increased proliferation and development of EMT but also in intratumor lymphangiogenesis 30 . These results indicate possible influence of EGFR-inhibitor therapy.
Finally, administration of a fibroblast inhibitor (transilat) used to treat hypertrophic scars and keloids in an in vivo model significantly suppresed tumor growth and cervical lymph node metastasis occurence in nude mice 26 . This biological interaction may be clinically relevant targeted therapy in patients with oral squamous cell carcinoma.
This study has all limitations associated with retrospective study. Another clear weakness of this analysis is inability to test molecular mechanisms by which myofibroblasts contribute to   biological aggressivness of OSCCs. Although we have demonstrated that increase in myofibroblasts correlates with higher T stage, another possible explanation for this phenomenon is that myofibroblasts could just be a marker for more advanced disease and as such have no prognostic value beyond the clinical T size. Further investigations are needed to clarify whether these stromal cells can act as separate prognostic marker, or whether they merely reflect primary tumor size. Also, large prospective studies are necessary to clarify if the number of myofibroblasts in the tumor stroma (determined preoperatively in biopsy material) can help in decision making regarding the need for elective neck dissection or radiotherapy after surgical treatment. On the other hand, we believe that this data provide insights into important prognosticators which may be useful to define optimal treatment of OSCC in elective settings.
In conclusion, we have demonstrated that an abundant presence of myofibroblasts leads to a more aggressive phenotype of the OSCCs, resulting in a significantly increased presence of occult metastases, regional recurrence and distant metastases as well as lower survival rates.
The multivariate model derived from this study identified high myofibroblast score as independent predictor of occult neck disease thus determining the patients most likely to benefit from elective neck dissection. Therefore, myofibroblasts in oral cancer facilitate tumor growth and metastatic spread. Further investigations of stromal interactions and phenotypic characteristics of myofibroblasts at the invasive front are needed in order to provide new diagnostic markers or anti-cancer therapeutic modalities. 
